GO:0035461 vitamin transmembrane transport: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0035461 vitamin transmembrane transport describes the movement of vitamins across biological membranes, a process essential for normal metabolism.
• Key molecular players include the retinol-binding protein receptor STRA6 for vitamin A, and the lysosomal transporter ABCD4 for vitamin B12.
• Defects in vitamin transmembrane transport contribute to diseases such as cystic fibrosis, where fat-soluble vitamin malabsorption is common.
• The process is regulated at the level of transporter expression, substrate availability, and post-translational modifications.
• Experimental models for studying this process include CRISPR knockout, point-mutation, and knock-in cell lines targeting transporters like STRA6 and ABCD4.
• Understanding vitamin transmembrane transport is critical for developing therapies for nutritional deficiencies and related metabolic disorders.
Description
Vitamin transmembrane transport (GO:0035461) is a biological process defined as the movement of vitamins across a membrane. Vitamins are essential organic micronutrients required in trace amounts for normal metabolic functioning, and their transport across cellular membranes is a prerequisite for their utilization. This process is mediated by specific transporter proteins that ensure vitamins reach their intracellular targets. Research into vitamin transmembrane transport has revealed dedicated molecular machinery for different vitamins. For example, the transmembrane receptor STRA6 mediates bidirectional transport of vitamin A (retinol), while the lysosomal transporter ABCD4 is indispensable for cobalamin (vitamin B12) transport. These transporters are critical for maintaining vitamin homeostasis, and their dysfunction is linked to a range of pathological conditions. Understanding the mechanisms, regulation, and disease relevance of vitamin transmembrane transport is essential for researchers in nutrition, metabolism, and membrane biology. This article synthesizes current knowledge based on authoritative QuickGO data and verified PubMed literature, providing a comprehensive overview for experimental design and therapeutic development.
vitamin transmembrane transport At A Glance
| GO ID | GO:0035461 |
|---|---|
| GO term | vitamin transmembrane transport |
| Ontology | biological_process |
| Synonym | vitamin membrane transport |
| Major function | Transport of vitamins across biological membranes |
| Definition | The process in which a vitamin is transported across a membrane. |
| Related transporters | STRA6, ABCD4, and other vitamin-specific transporters |
| Disease relevance | Cystic fibrosis, nutritional deficiencies, metabolic disorders |
What Is GO:0035461?
GO:0035461 vitamin transmembrane transport is the process in which a vitamin is transported across a membrane. A vitamin is one of a number of unrelated organic substances that occur in many foods in small amounts and that are necessary in trace amounts for the normal metabolic functioning of the body. This process encompasses the movement of vitamins from one side of a membrane to the other, typically mediated by specific transporter proteins.
Why Is vitamin transmembrane transport Important in Cell Biology?
Vitamin transmembrane transport is fundamental to human health because vitamins cannot be synthesized endogenously in sufficient amounts and must be obtained from the diet and transported into cells. Defects in this process lead to vitamin deficiencies and associated diseases, such as cystic fibrosis where impaired fat-soluble vitamin absorption is common. Understanding the molecular mechanisms of vitamin transport is therefore critical for developing therapeutic strategies and for interpreting genetic variants in transporter genes.
• Vitamins are essential micronutrients that require membrane transport for cellular uptake and function.
• Dedicated transporters such as STRA6 and ABCD4 ensure specific and regulated vitamin transport.
• Impaired vitamin transport contributes to cystic fibrosis-related nutritional deficiencies.
• Vitamin A transport by STRA6 is critical for vision, immunity, and embryonic development.
• Vitamin B12 transport by ABCD4 is essential for neurological function and red blood cell formation.
• Mutations in transporter genes can cause rare inherited disorders of vitamin metabolism.
• Understanding transport mechanisms aids in designing vitamin supplementation strategies.
• Vitamin transmembrane transport is a target for drug development in metabolic and nutritional diseases.
What Happens During vitamin transmembrane transport?
Substrate Recognition and Binding
In simple terms: The transporter protein recognizes and binds the specific vitamin it is designed to carry.
The first step in vitamin transmembrane transport is the specific recognition of the vitamin substrate by its transporter. For example, the transmembrane receptor STRA6 binds retinol-binding protein (RBP) carrying vitamin A, facilitating the transfer of retinol across the membrane. This binding is highly specific and ensures that only the correct vitamin is transported. Similarly, ABCD4 recognizes cobalamin (vitamin B12) and initiates its transport across the lysosomal membrane.
Conformational Changes and Membrane Translocation
In simple terms: The transporter changes shape to move the vitamin through the membrane.
Upon substrate binding, the transporter undergoes conformational changes that allow the vitamin to pass through the lipid bilayer. In STRA6, a transmembrane pore facilitates the bidirectional movement of retinol. For ABCD4, transmembrane helix 6 is indispensable for cobalamin transport, highlighting the importance of specific structural elements in the translocation process. These conformational dynamics are tightly regulated to maintain vitamin homeostasis.
Release and Intracellular Delivery
In simple terms: Once inside the cell, the vitamin is released for use.
After translocation, the vitamin is released into the cytoplasm or appropriate intracellular compartment. For vitamin A, retinol is delivered to target proteins or enzymes for conversion to active metabolites. For vitamin B12, cobalamin is released into the cytosol for utilization in methionine synthesis and other pathways. This release step is crucial for the vitamin to exert its metabolic functions.
Regulation of Transport Activity
In simple terms: The cell controls how much vitamin is transported based on its needs.
Vitamin transmembrane transport is regulated at multiple levels, including transporter expression, post-translational modifications, and substrate availability. For instance, STRA6-mediated vitamin A transport can be modulated by its interaction with RBP and cellular retinol-binding proteins. ABCD4 activity may be influenced by lysosomal conditions and interacting proteins. This regulation ensures that vitamin levels are maintained within physiological ranges.
Key Genes Involved in GO:0035461 vitamin transmembrane transport
The following genes encode proteins that mediate or regulate vitamin transmembrane transport, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| STRA6 | Transmembrane receptor for retinol-binding protein, mediating vitamin A transport | Studied for vitamin A homeostasis, vision, and embryonic development |
| ABCD4 | Lysosomal transporter for cobalamin (vitamin B12) | Linked to vitamin B12 metabolism and neurological disorders |
| RBP4 | Carrier protein for retinol in plasma, delivers vitamin A to STRA6 | Biomarker for vitamin A status and metabolic diseases |
| CFTR | Chloride channel; mutations cause cystic fibrosis, affecting fat-soluble vitamin absorption | Model for studying vitamin transport in cystic fibrosis |
| SLC13A1 | Sodium-sulfate cotransporter; may influence sulfate-dependent vitamin transport | Investigated for sulfate homeostasis and related transport |
| RFFL | E3 ubiquitin ligase; regulates CFTR stability, indirectly affecting vitamin transport | Target for modulating CFTR and vitamin absorption |
| TTPA | Alpha-tocopherol transfer protein; not a transmembrane transporter but involved in vitamin E distribution | Studied in vitamin E deficiency and ataxia |
| SLC5A6 | Sodium-dependent multivitamin transporter (SMVT) | Broad specificity for biotin, pantothenate, and lipoate |
| SLC19A1 | Reduced folate carrier; transports folate (vitamin B9) | Important for folate metabolism and cancer chemotherapy |
| SLC19A2 | Thiamine transporter; mediates vitamin B1 uptake | Mutations cause thiamine-responsive megaloblastic anemia |
| SLC19A3 | Thiamine transporter; brain-specific | Linked to biotin-responsive basal ganglia disease |
| SLC23A1 | Sodium-dependent vitamin C transporter 1 (SVCT1) | Studied for vitamin C homeostasis and antioxidant defense |
| SLC23A2 | Sodium-dependent vitamin C transporter 2 (SVCT2) | Critical for vitamin C uptake in brain and other tissues |
| SLC46A1 | Proton-coupled folate transporter (PCFT) | Mediates intestinal folate absorption |
| SLC52A1 | Riboflavin transporter | Defects cause riboflavin deficiency and related disorders |
| SLC52A2 | Riboflavin transporter | Associated with Brown-Vialetto-Van Laere syndrome |
| SLC52A3 | Riboflavin transporter | Mutations linked to riboflavin transporter deficiency |
| CUBN | Cubilin; receptor for intrinsic factor-vitamin B12 complex in ileum | Studied for vitamin B12 absorption and megaloblastic anemia |
How Is vitamin transmembrane transport Regulated?
Vitamin transmembrane transport is regulated by multiple mechanisms to maintain vitamin homeostasis. Transcriptional regulation of transporter genes, such as STRA6 and ABCD4, controls the capacity for vitamin uptake. Post-translational modifications, including ubiquitination by RFFL, can affect the stability of transporters like CFTR, indirectly influencing vitamin transport. Additionally, substrate availability and feedback mechanisms adjust transport activity to meet cellular demands.
vitamin transmembrane transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CFTR | Cystic fibrosis; fat-soluble vitamin malabsorption | CFTR knockout or point-mutation cell lines |
| STRA6 | Matthew-Wood syndrome; vitamin A transport defect | STRA6 knockout or knock-in cell models |
| ABCD4 | Methylmalonic aciduria and homocystinuria; vitamin B12 transport defect | ABCD4 knockout or point-mutation cell lines |
| RBP4 | Vitamin A deficiency; metabolic disorders | RBP4 overexpression or knockout models |
| RFFL | CFTR stability; indirect effects on vitamin transport | RFFL knockout or overexpression cell lines |
Cystic Fibrosis and Fat-Soluble Vitamin Malabsorption
Cystic fibrosis (CF) is caused by mutations in the CFTR gene and leads to impaired fat-soluble vitamin absorption, including vitamins A, D, E, and K. This malabsorption results from pancreatic insufficiency and defective transmembrane transport mechanisms. Nutritional care in children with CF often includes high-dose vitamin supplementation to compensate for these defects. Research into vitamin transmembrane transport in CF models can elucidate the molecular basis of these deficiencies and guide therapeutic strategies.
Vitamin A Transport Defects and Developmental Disorders
STRA6-mediated vitamin A transport is critical for embryonic development, vision, and immune function. Mutations in STRA6 can cause Matthew-Wood syndrome, characterized by severe developmental abnormalities. Studying the bidirectional transport mechanism of STRA6 provides insights into how vitamin A deficiency leads to congenital defects.
Vitamin B12 Transport and Neurological Disease
ABCD4 is indispensable for cobalamin (vitamin B12) transport from lysosomes to the cytoplasm. Defects in ABCD4 cause methylmalonic aciduria and homocystinuria, leading to neurological impairment. Understanding the structural requirements, such as transmembrane helix 6, is essential for diagnosing and treating these disorders.
From vitamin transmembrane transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of STRA6 loss on vitamin A transport? | STRA6 knockout cell line (e.g., HEK293) |
| How do point mutations in ABCD4 affect cobalamin transport? | ABCD4 point-mutation knock-in cell lines |
| Can overexpression of SLC5A6 enhance multivitamin uptake? | SLC5A6 overexpression cell line |
| What is the role of CFTR in vitamin E transport? | CFTR knockout or point-mutation models |
| How does RFFL regulate CFTR and vitamin transport? | RFFL knockout or tagged knock-in cell lines |
| What is the impact of SLC23A2 on vitamin C transport in neurons? | SLC23A2 knockout or overexpression neuronal cells |
How to Study the vitamin transmembrane transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled uptake assay | Transport activity of specific vitamins | Quantifying STRA6 or ABCD4 function |
| Fluorescence microscopy | Real-time vitamin transport and localization | Visualizing STRA6-mediated retinol uptake |
| CRISPR knockout | Loss-of-function effects on transport | Validating transporter genes |
| CRISPR knock-in | Effect of point mutations on transport | Structure-function studies of ABCD4 |
| RNA-seq | Transcriptional changes in transporter genes | Identifying regulatory pathways |
| Proteomics | Protein expression and interactions | Discovering novel transport regulators |
| Western blot | Protein levels of transporters | Confirming knockout or overexpression |
| Co-immunoprecipitation | Protein-protein interactions | Studying STRA6-RBP interactions |
Transport Assays Using Radiolabeled Vitamins
Radiolabeled vitamin uptake assays are a direct method to measure transmembrane transport activity. For example, 3H-retinol uptake in STRA6-expressing cells can quantify vitamin A transport. Similarly, 57Co-labeled vitamin B12 uptake assays assess ABCD4 function. These assays are typically performed in cell lines with controlled expression of the transporter of interest.
Fluorescence-Based Imaging of Vitamin Transport
Fluorescent vitamin analogs or genetically encoded sensors can visualize transport in real time. For instance, fluorescent retinol derivatives have been used to track STRA6-mediated transport. Live-cell imaging allows researchers to monitor the dynamics of vitamin translocation and subcellular localization.
Genetic Knockout and Knock-in Models
CRISPR-Cas9 technology enables the generation of knockout and knock-in cell lines to study vitamin transporters. Knockout of STRA6 or ABCD4 abolishes transport activity, while knock-in of specific point mutations can reveal structure-function relationships. These models are essential for validating the role of candidate genes in vitamin transmembrane transport.
Proteomic and Transcriptomic Profiling
RNA-seq and proteomics can identify changes in transporter expression under different conditions. For example, vitamin deficiency may upregulate specific transporters. These global approaches help uncover regulatory networks and potential therapeutic targets related to vitamin transport.
How CRISPR Can Be Used to Study GO:0035461 vitamin transmembrane transport
Knockout
CRISPR knockout of vitamin transporter genes such as STRA6 or ABCD4 completely abolishes transport activity, providing a clean background to study the specific contribution of these proteins. Knockout cell lines are valuable for confirming the essentiality of a transporter and for identifying compensatory mechanisms.
Point Mutation
Introducing precise point mutations via CRISPR base editing or homology-directed repair allows researchers to dissect the functional domains of transporters. For example, mutations in transmembrane helix 6 of ABCD4 can reveal its role in cobalamin transport. Point-mutation models are crucial for understanding disease-associated variants.
Knock-in
Knock-in of tagged versions of transporters (e.g., GFP-STRA6) enables visualization and biochemical purification. This approach helps track the localization and dynamics of vitamin transporters in live cells. Knock-in models can also be used to express mutant transporters under endogenous regulatory control.
Overexpression
Overexpression of vitamin transporters such as SLC5A6 or SLC23A2 can enhance vitamin uptake and is useful for studying transport kinetics and substrate specificity. Overexpression models are also employed to screen for inhibitors or activators of transport.
How EDITGENE Supports vitamin transmembrane transport Research
Researchers studying vitamin transmembrane transport-related genes often need to determine whether a candidate gene is causally involved in vitamin uptake, metabolism, or disease. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional studies of transporters like STRA6, ABCD4, and others.
Contact EDITGENE today to design your custom CRISPR model for vitamin transmembrane transport research.
Frequently Asked Questions About vitamin transmembrane transport
What is vitamin transmembrane transport?
Vitamin transmembrane transport (GO:0035461) is the biological process in which vitamins are moved across cellular membranes by specific transporter proteins.
What genes are involved in vitamin transmembrane transport?
Key genes include STRA6 for vitamin A, ABCD4 for vitamin B12, and various SLC family transporters for other vitamins.
How does vitamin A cross the cell membrane?
Vitamin A (retinol) is transported by the transmembrane receptor STRA6, which binds retinol-binding protein and facilitates retinol transfer across the membrane.
What is the role of ABCD4 in vitamin B12 transport?
ABCD4 is a lysosomal transporter essential for cobalamin (vitamin B12) transport; mutations in ABCD4 cause methylmalonic aciduria and homocystinuria.
How is vitamin transmembrane transport studied?
Common methods include radiolabeled uptake assays, fluorescence imaging, CRISPR knockout/knock-in models, and omics profiling.
What diseases are linked to defective vitamin transport?
Cystic fibrosis (fat-soluble vitamin malabsorption), Matthew-Wood syndrome (vitamin A transport defect), and vitamin B12-related neurological disorders.
Can CRISPR be used to study vitamin transporters?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect transporter function and disease mechanisms.
What is the function of STRA6?
STRA6 is a cell-surface receptor that mediates bidirectional transport of vitamin A (retinol) and is critical for vision, immunity, and development.
How does cystic fibrosis affect vitamin transport?
Cystic fibrosis impairs pancreatic function and fat absorption, leading to deficiencies in fat-soluble vitamins A, D, E, and K.
What are the research methods for vitamin transmembrane transport?
Methods include transport assays, imaging, genetic editing, and high-throughput screening to identify regulators and therapeutic targets.
Conclusion
Vitamin transmembrane transport (GO:0035461) is a vital biological process that ensures cellular uptake of essential micronutrients. Dedicated transporters such as STRA6 and ABCD4 mediate the specific and regulated movement of vitamins across membranes, and their dysfunction is linked to diseases including cystic fibrosis and neurological disorders. Continued research using advanced CRISPR models and omics approaches will further elucidate the mechanisms and therapeutic potential of targeting vitamin transport pathways.
References
- 1. Dickinson KM et al.. 2021. Cystic Fibrosis.. Pediatr Rev 42(2):55-67 PMID: 33526571
- 2. Mariotti Zani E et al.. 2023. Nutritional Care in Children with Cystic Fibrosis.. Nutrients 15(3) PMID: 36771186
- 3. Zhong M et al.. 2020. Regulatory mechanism for the transmembrane receptor that mediates bidirectional vitamin A transport.. Proc Natl Acad Sci U S A 117(18):9857-9864 PMID: 32300017
- 4. Taniguchi S et al.. 2023. Identification of α-Tocopherol succinate as an RFFL-substrate interaction inhibitor inducing peripheral CFTR stabilization and apoptosis.. Biochem Pharmacol 215:115730 PMID: 37543348
- 5. Markovich D. 2014. Na+-sulfate cotransporter SLC13A1.. Pflugers Arch 466(1):131-7 PMID: 24193406
- 6. Paccou J et al.. 2013. Cystic fibrosis-related bone disease.. Curr Opin Pulm Med 19(6):681-6 PMID: 24060979
- 7. Zhong M et al.. 2013. Vitamin A transport and the transmembrane pore in the cell-surface receptor for plasma retinol binding protein.. PLoS One 8(11):e73838 PMID: 24223695
- 8. Imai M et al.. 2024. Transmembrane helix 6 of ABCD4 is indispensable for cobalamin transport.. J Inherit Metab Dis 47(2):366-373 PMID: 38069516
